4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000950170-24-131098
Chief Financial Officer bought 15,000 shares at $0.59 ($8,850)
From the SEC's structured data for this filing
Trades in this filing
Howe Jill Ann · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-26 | Purchase : show line 1 in the form | +15,000 | $0.59 | $8,850 | 25,500 | D |
| Open-market purchases · 15,000 sh · avg $0.59 · $8,850 | ||||||
Loading xslF345X05/ownership.xml…